DENTSPLY SIRONA’s (XRAY) Buy Rating Reiterated at Needham & Company LLC

Needham & Company LLC reiterated their buy rating on shares of DENTSPLY SIRONA (NASDAQ:XRAY) in a research report report published on Tuesday morning,Benzinga reports. Needham & Company LLC currently has a $25.00 price target on the medical instruments supplier’s stock.

Other equities analysts have also issued reports about the company. Mizuho started coverage on DENTSPLY SIRONA in a report on Wednesday, December 4th. They set a “neutral” rating and a $21.00 target price on the stock. Morgan Stanley cut their target price on DENTSPLY SIRONA from $30.00 to $23.00 and set an “overweight” rating on the stock in a report on Tuesday, December 17th. Evercore ISI restated an “in-line” rating and set a $20.00 target price on shares of DENTSPLY SIRONA in a report on Tuesday, January 7th. UBS Group cut their price objective on DENTSPLY SIRONA from $35.00 to $27.00 and set a “buy” rating for the company in a research report on Tuesday, December 3rd. Finally, Leerink Partnrs cut DENTSPLY SIRONA from a “strong-buy” rating to a “hold” rating in a research report on Thursday, November 7th. Nine equities research analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $26.33.

DENTSPLY SIRONA Price Performance

NASDAQ XRAY opened at $18.77 on Tuesday. DENTSPLY SIRONA has a fifty-two week low of $17.21 and a fifty-two week high of $34.91. The stock’s 50-day moving average is $19.04 and its two-hundred day moving average is $22.04. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84. The firm has a market cap of $3.73 billion, a P/E ratio of -9.07, a price-to-earnings-growth ratio of 1.83 and a beta of 0.96.

DENTSPLY SIRONA Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, January 10th. Stockholders of record on Friday, December 27th were paid a $0.16 dividend. The ex-dividend date was Friday, December 27th. This represents a $0.64 annualized dividend and a dividend yield of 3.41%. DENTSPLY SIRONA’s dividend payout ratio is currently -30.92%.

Institutional Investors Weigh In On DENTSPLY SIRONA

A number of large investors have recently bought and sold shares of XRAY. Pacer Advisors Inc. grew its position in DENTSPLY SIRONA by 15,105.1% during the 4th quarter. Pacer Advisors Inc. now owns 4,503,591 shares of the medical instruments supplier’s stock worth $85,478,000 after acquiring an additional 4,473,972 shares during the last quarter. Nuance Investments LLC grew its position in DENTSPLY SIRONA by 25.0% during the 4th quarter. Nuance Investments LLC now owns 13,545,981 shares of the medical instruments supplier’s stock worth $257,103,000 after acquiring an additional 2,708,097 shares during the last quarter. Norges Bank bought a new stake in DENTSPLY SIRONA during the 4th quarter worth approximately $45,730,000. Cooke & Bieler LP boosted its position in DENTSPLY SIRONA by 24.3% in the 4th quarter. Cooke & Bieler LP now owns 9,172,876 shares of the medical instruments supplier’s stock valued at $174,101,000 after buying an additional 1,794,391 shares during the last quarter. Finally, JPMorgan Chase & Co. lifted its stake in shares of DENTSPLY SIRONA by 206.3% in the 3rd quarter. JPMorgan Chase & Co. now owns 1,847,389 shares of the medical instruments supplier’s stock valued at $49,990,000 after purchasing an additional 1,244,326 shares during the period. 95.70% of the stock is currently owned by institutional investors.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.